Jyoti Nangalia

Researcher Next ID · RN-027578

Researcher · Biochemistry, Genetics and Molecular Biology

Cambridge, Portugal

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Cancer Genomics and Diagnostics

Myeloproliferative Neoplasms: Diagnosis and Treatment

Acute Myeloid Leukemia Research

Chronic Myeloid Leukemia Treatments

Kruppel-like factors research

Life histories of myeloproliferative neoplasms inferred from phylogenies.
RePEc: Research Papers in Economics · 2022 · https://doi.org/10.17863/cam.80309
Clonal dynamics of haematopoiesis across the human lifespan
Nature · 2022 · https://doi.org/10.1038/s41586-022-04786-y
Extensive heterogeneity in somatic mutation and selection in the human bladder
Science · 2020 · https://doi.org/10.1126/science.aba8347
The mutational landscape of normal human endometrial epithelium
Nature · 2020 · https://doi.org/10.1038/s41586-020-2214-z
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716614
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial
The Lancet Haematology · 2017 · https://doi.org/10.1016/s2352-3026(17)30027-3
Effect of Mutation Order on Myeloproliferative Neoplasms
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1412098
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
eLife · 2014 · https://doi.org/10.7554/elife.02935
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1312542

No projects listed.